Interleukin-17 in rheumatoid arthritis: if T cells were to contribute to inflammation and destruction through synergy.
Miossec
Pierre
P
Department of Rheumatology, Hospital Edouard Herriot, Lyon, France. miossec@univ-lyon.fr
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000276:immunology*; D002478:Cells, Cultured; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006801:Humans; D020381:Interleukin-17 / Q000276:immunology* / Q000378:metabolism / Q000494:pharmacology; D007596:Joints / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D051379:Mice; D013583:Synovial Membrane / Q000187:drug effects / Q000378:metabolism / Q000473:pathology; D013585:Synovitis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D013601:T-Lymphocytes / Q000276:immunology*
D020381:Interleukin-17